RTI Surgical announced a new agreement with Oxford Performance Materials.
Here are four takeaways:
1. The agreement gives RTI an exclusive license to OPM's OsteoFab technology platform for spinal applications in all U.S. markets.
2. Under the agreement, OPM will manufacture RTI's spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.
3. OsteoFab is a next-generation implant manufacturing process using laser light and OPM's OXPEKK polymer.
4. The OsteoFab process aims to create implants that are designed to enable bone ongrowth.